Literature DB >> 19641276

Neuro-ophthalmologic manifestations of benign anterior skull base lesions.

Mark Hornyak1, Kathleen Digre, William T Couldwell.   

Abstract

Visual disturbance is a common presenting symptom of anterior skull base lesions. These lesions cause deterioration in visual acuity, restriction of the visual field, or reduction of ocular mobility. Common pathological entities that affect the skull base and involve vision include meningioma, pituitary adenoma, tumors of the bone, malignancy, and infection. Benign lesions are typically treated surgically with acceptable long-term results. In this article, we review the presentation, evaluation, and surgical treatment of patients with benign skull base lesions presenting with visual disturbance.

Entities:  

Mesh:

Year:  2009        PMID: 19641276     DOI: 10.3810/pgm.2009.07.2036

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  Isolated sixth cranial nerve palsy as the presenting symptom of a rapidly expanding ACTH positive pituitary adenoma: a case report.

Authors:  Norman Saffra; Elizabeth Kaplow; Irina Mikolaenko; Alice Kim; Benjamin Rubin; Jafar Jafar
Journal:  BMC Ophthalmol       Date:  2011-01-27       Impact factor: 2.209

2.  Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.

Authors:  Manju Jayaraman; S Ambika; Rashmin Anilkumar Gandhi; Shikha Rajesh Bassi; Priya Ravi; Parveen Sen
Journal:  Doc Ophthalmol       Date:  2010-09-04       Impact factor: 2.379

3.  Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.

Authors:  Manju Jayaraman; Rashmin Anilkumar Gandhi; Priya Ravi; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

4.  Analyses and treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms.

Authors:  You Cheng; Fei Xue; Tian-You Wang; Jun-Feng Ji; Wei Chen; Zhi-Yi Wang; Li Xu; Chun-Hua Hang; Xin-Feng Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.